atropine has been researched along with erythromycin in 47 studies
Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (erythromycin) | Trials (erythromycin) | Recent Studies (post-2010) (erythromycin) |
---|---|---|---|---|---|
26,711 | 1,259 | 1,697 | 14,524 | 1,138 | 1,926 |
Protein | Taxonomy | atropine (IC50) | erythromycin (IC50) |
---|---|---|---|
30S ribosomal protein S6 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S7 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L15 | Escherichia coli K-12 | 1.156 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 1.045 | |
50S ribosomal protein L10 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L11 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L7/L12 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L19 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L1 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L20 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L27 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L28 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L29 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L31 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L31 type B | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L32 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L33 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L34 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L35 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L36 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S10 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S11 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S12 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S13 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S16 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S18 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S19 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S20 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S2 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S3 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S4 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S5 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S8 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S9 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L13 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L14 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L16 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L23 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S15 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L17 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L21 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L30 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L6 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S14 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S17 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S1 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L18 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L2 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L3 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L24 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L4 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L22 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L5 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S21 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L25 | Escherichia coli K-12 | 1.156 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.039 | |
50S ribosomal protein L36 2 | Escherichia coli K-12 | 1.156 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (10.64) | 18.7374 |
1990's | 19 (40.43) | 18.2507 |
2000's | 14 (29.79) | 29.6817 |
2010's | 9 (19.15) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Forth, W; Holle, GE; Steinbach, E | 1 |
Bosso, R; Fiorucci, S; Morelli, A | 1 |
Jansen, JB; Jebbink, MC; Lamers, CB; Masclee, AA; Rovati, LC; Schipper, J; van der Kleij, FG | 1 |
Bosso, R; Bottini, P; Desando, A; Fiorucci, S; Marino, C; Morelli, A; Scionti, L | 1 |
Baker, RA; Costi, D; Saccone, GT; Thune, A; Toouli, J | 1 |
Inatomi, N; Itoh, Z; Marui, S; Omura, S; Satoh, H; Satoh, T | 1 |
Hashimoto, N; Inatomi, N; Itoh, Z; Maki, Y; Omura, S; Satoh, H | 1 |
Wakabayashi, K; Yamada, S | 1 |
Bellows, AR; Grant, WM | 1 |
Boruchoff, SA; Dohlman, CH | 1 |
Inoue, M; Itoh, Z; Mitsuhashi, S; Nakaya, M; Suzuki, T | 1 |
Haga, N; Inatomi, N; Itoh, Z; Mizumoto, A; Shiba, Y; Yamamoto, O | 1 |
Bruley des Varannes, S; Chayvialle, JA; Galmiche, JP; Parys, V; Ropert, A; Rozé, C | 1 |
Falcucci, M; Grossi, L; Lapenna, D; Martelli, L; Marzio, L | 1 |
Pilot, MA; Qin, XY; Scott, M; Thompson, H | 1 |
Inatomi, N; Itoh, Z; Omura, S; Satoh, H; Satoh, T | 1 |
Fiorucci, S; Morelli, A | 1 |
Hayashi, N; Itoh, Z; Mizumoto, A; Ohtawa, M; Omura, S; Yanagida, K | 1 |
Inui, A; Itoh, Z; Mizumoto, A; Omura, S; Satoh, M; Shiba, Y | 1 |
Arruebo, MP; Murillo, MD; Plaza, MA | 1 |
Arruebo, MP; Guerrero-Lindner, E; Murillo, MD; Plaza, MA | 1 |
Costa, A; Crema, F; d'Angelo, L; De Ponti, F; Gibelli, G | 1 |
Andrews, FM; Doherty, TJ; Frazier, DL; Provenza, MK | 1 |
Coulie, B; Janssens, J; Peeters, T; Tack, J | 1 |
Inatomi, N; Itoh, Z; Marui, S; Omura, S; Sato, F | 1 |
Gonzalez, A; Ryan, RP; Sarna, SK | 1 |
Athanasakis, H; Chrysos, E; Epanomeritakis, E; Koutsoumbi, P; Tsiaoussis, J; Vassilakis, JS; Xynos, E; Zoras, O | 1 |
Burton, DD; Camilleri, M; Kim, DY; Klein, PD; Lee, JS; Stephens, D; Thomforde, GM; Viramontes, BE; Zinsmeister, AR | 1 |
Asao, T; Haga, N; Kamiyama, Y; Kuwano, H; Mochiki, E; Nakabayashi, T | 1 |
Elliott, RA; England, RC; Norman, RI | 1 |
Baxter, K; Burton, D; Camilleri, M; Castillo, EJ; Cremonini, F; Delgado-Aros, S; Ferber, I; Stephens, D; Zinsmeister, AR | 1 |
Itoh, Z; Koga, H; Omura, S; Ozaki, K; Takanashi, H; Yogo, K | 1 |
Hoshino, S; Koike, K; Oda, S; Sakahara, S; Sakai, T; Sakata, I; Takahashi, T; Xie, Z | 1 |
2 review(s) available for atropine and erythromycin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Penetrating keratoplasty.
Topics: Adrenal Cortex Hormones; Anesthesia, Local; Anterior Chamber; Atropine; Cataract Extraction; Cornea; Corneal Injuries; Corneal Transplantation; Edema; Erythromycin; Eye Diseases; Hospitalization; Humans; Intraocular Pressure; Methods; Phenylephrine; Postoperative Care; Preoperative Care; Prognosis; Refraction, Ocular; Suture Techniques; Tissue Donors; Tissue Preservation; Transplantation, Autologous; Transplantation, Homologous; Visual Acuity | 1968 |
5 trial(s) available for atropine and erythromycin
Article | Year |
---|---|
Erythromycin enhances fasting and postprandial proximal gastric tone in humans.
Topics: Adult; Analysis of Variance; Atropine; Eating; Erythromycin; Fasting; Female; Humans; Infusions, Intravenous; Male; Motilin; Muscle Contraction; Regression Analysis; Stimulation, Chemical; Stomach | 1995 |
Involvement of two different pathways in the motor effects of erythromycin on the gastric antrum in humans.
Topics: Anti-Bacterial Agents; Atropine; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythromycin; Gastrointestinal Motility; Humans; Manometry; Muscarinic Antagonists; Myoelectric Complex, Migrating; Pyloric Antrum; Serotonin Antagonists; Sumatriptan | 1998 |
The effect of erythromycin on human esophageal motility is mediated by serotonin receptors.
Topics: Adult; Atropine; Double-Blind Method; Erythromycin; Esophagus; Female; Gastrointestinal Agents; Humans; Male; Manometry; Ondansetron; Peristalsis; Receptors, Serotonin | 2000 |
Validation of a stable isotope gastric emptying test for normal, accelerated or delayed gastric emptying.
Topics: Adolescent; Adult; Aging; Algorithms; Anti-Bacterial Agents; Atropine; Bacterial Proteins; Breath Tests; Carbon Dioxide; Carbon Isotopes; Erythromycin; Female; Gastric Emptying; Humans; Linear Models; Male; Middle Aged; Models, Statistical; Parasympatholytics; Sex Characteristics; Spirulina | 2001 |
Effect of gastric volume or emptying on meal-related symptoms after liquid nutrients in obesity: a pharmacologic study.
Topics: Adolescent; Adult; Aged; Atropine; Double-Blind Method; Erythromycin; Female; Gastric Emptying; Humans; Male; Middle Aged; Obesity; Pancreatic Polypeptide; Regression Analysis; Stomach | 2005 |
40 other study(ies) available for atropine and erythromycin
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Effects of erythromycin in the dog upper gastrointestinal tract.
Topics: Animals; Atropine; Digestive System; Dogs; Electrophysiology; Erythromycin; Female; Ganglionic Blockers; Gastrointestinal Diseases; Gastrointestinal Motility; Hexamethonium; Hexamethonium Compounds; Male; Neostigmine | 1992 |
Erythromycin stimulates gallbladder emptying and motilin release by atropine-sensitive pathways.
Topics: Adult; Analysis of Variance; Atropine; Dose-Response Relationship, Drug; Erythromycin; Fasting; Female; Gallbladder; Gallbladder Emptying; Humans; Male; Middle Aged; Motilin; Reference Values; Somatostatin; Time Factors; Ultrasonography | 1992 |
Effect of loxiglumide and atropine on erythromycin-induced reduction in gallbladder volume in human subjects.
Topics: Adult; Atropine; Cholecystokinin; Erythromycin; Female; Gallbladder; Humans; Male; Pancreatic Polypeptide; Proglumide; Pulse; Ultrasonography | 1992 |
Effect of erythromycin on gallbladder emptying in diabetic patients with and without autonomic neuropathy and high levels of motilin.
Topics: Adult; Analysis of Variance; Atropine; Autonomic Nervous System Diseases; Diabetic Neuropathies; Erythromycin; Female; Gallbladder; Gallbladder Emptying; Heart Diseases; Humans; Male; Motilin; Ultrasonography | 1992 |
Motilin and erythromycin enhance the in vitro contractile activity of the sphincter of Oddi of the Australian brush-tailed possum.
Topics: Animals; Atropine; Calcium; Calcium Channel Blockers; Electrophysiology; Erythromycin; Gallbladder; Motilin; Muscle Contraction; Muscle, Smooth; Opossums; Sphincter of Oddi | 1992 |
EM-523, an erythromycin derivative, and motilin show similar contractile activity in isolated rabbit intestine.
Topics: Acetylcholine; Animals; Atropine; Dinoprost; Drug Interactions; Erythromycin; Female; Guinea Pigs; Intestine, Small; Male; Motilin; Muscle Contraction; Muscle, Smooth; Rabbits; Rats; Rats, Inbred Strains; Species Specificity; Tetrodotoxin | 1990 |
An erythromycin derivative, EM-523, induces motilin-like gastrointestinal motility in dogs.
Topics: Animals; Atropine; Dogs; Erythromycin; Fasting; Gastrointestinal Motility; Male; Motilin; Receptors, Gastrointestinal Hormone; Receptors, Neuropeptide; Vomiting | 1989 |
Effects of several macrolide antibiotics on blood pressure of dogs.
Topics: Animals; Anti-Bacterial Agents; Atropine; Biological Assay; Blood Pressure; Cordotomy; Diphenhydramine; Dogs; Erythromycin; Female; Glycosides; Guinea Pigs; Histamine; Ileum; In Vitro Techniques; Lactones; Leucomycins; Male; Muscle Contraction; Oleandomycin; Parasympathetic Nervous System; Sympathectomy; Tachyphylaxis; Vagotomy | 1972 |
Cyclocryotherapy in advanced inadequately controlled glaucoma.
Topics: Adolescent; Adult; Aged; Atropine; Cryosurgery; Dexamethasone; Erythromycin; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Male; Methods; Middle Aged; Postoperative Complications; Prednisone; Tonometry, Ocular | 1973 |
Gastrointestinal motor-stimulating activity of macrolide antibiotics and analysis of their side effects on the canine gut.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Atropine; Binding, Competitive; Dogs; Dose-Response Relationship, Drug; Erythromycin; Female; Gastrointestinal Motility; Leucomycins; Male; Micrococcus; Muscle Contraction; Oleandomycin | 1984 |
Stimulatory mechanism of EM523-induced contractions in postprandial stomach of conscious dogs.
Topics: Animals; Anti-Bacterial Agents; Atropine; Dipeptides; Dogs; Dopamine; Eating; Erythromycin; Hexamethonium; Indoles; Motilin; Muscle Contraction; Naloxone; Ondansetron; Serotonin Antagonists; Stomach; Substance P | 1995 |
Migrating motor complex recorded spontaneously and induced by motilin and erythromycin in an ex vivo rabbit intestinal preparation.
Topics: Animals; Atropine; Digestive System; Erythromycin; Esophagus; Female; Gastrointestinal Motility; In Vitro Techniques; Intestine, Small; Male; Motilin; Neostigmine; Rabbits; Stomach | 1994 |
Effects of cholinoceptor and 5-hydroxytryptamine3 receptor antagonism on erythromycin-induced canine intestinal motility disruption and emesis.
Topics: Animals; Atropine; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cholinergic Antagonists; Dogs; Electromyography; Erythromycin; Female; Gastrointestinal Motility; Hexamethonium; Hexamethonium Compounds; Injections, Intravenous; Intestine, Small; Male; Metoclopramide; Muscle Contraction; Muscle, Smooth; Serotonin Antagonists; Tropanes; Vomiting | 1993 |
Comparison of the motor-stimulating action of EM523, an erythromycin derivative, and prostaglandin F2 alpha in conscious dogs.
Topics: Animals; Atropine; Dinoprost; Dogs; Dopamine; Erythromycin; Fasting; Gastrointestinal Motility; Male; Motilin | 1993 |
Motilin and erythromycin stimulate pepsinogen secretion by chief cells isolated from guinea pig stomach.
Topics: Animals; Atropine; Calcium; Carbachol; Cholecystokinin; Dinoprostone; Erythromycin; Gastric Mucosa; Guinea Pigs; In Vitro Techniques; Kinetics; Male; Motilin; Pepsinogens; Secretin; Vasoactive Intestinal Peptide | 1993 |
Mechanism of gastroprokinetic effect of EM523, an erythromycin derivative, in dogs.
Topics: Animals; Atropine; Dogs; Dose-Response Relationship, Drug; Erythromycin; Female; Gastrointestinal Motility; Immune Sera; Male; Motilin | 1993 |
Effect of nonpeptide motilin agonist EM523 on release of gut and pancreatic hormones in conscious dogs.
Topics: Animals; Atropine; Dogs; Erythromycin; Gastrointestinal Hormones; Motilin; Ondansetron; Pancreatic Hormones; Serotonin Antagonists; Vagotomy | 1996 |
Effect of motilin, somatostatin and bombesin on gastroduodenal myoelectric activity in sheep.
Topics: Animals; Atropine; Bombesin; Duodenum; Electroencephalography; Erythromycin; Female; Gastrointestinal Motility; Hexamethonium; Motilin; Sheep; Somatostatin; Stomach | 1996 |
Effect of motilin on gastrointestinal myoelectric activity in conscious rabbits.
Topics: Animals; Atropine; Consciousness; Drug Interactions; Erythromycin; Gastrointestinal Agents; Hexamethonium; Motilin; Myoelectric Complex, Migrating; Ondansetron; Rabbits | 1996 |
In vivo characterization of the colonic prokinetic effect of erythromycin in the rabbit.
Topics: Animals; Anti-Bacterial Agents; Atropine; Calcium Channel Blockers; Colon; Dose-Response Relationship, Drug; Electrodes, Implanted; Erythromycin; Female; Gastrointestinal Motility; In Vitro Techniques; Male; Muscarinic Antagonists; Nifedipine; Ondansetron; Rabbits; Serotonin Antagonists; Stimulation, Chemical | 1997 |
Acetaminophen as a marker of gastric emptying in ponies.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Anti-Bacterial Agents; Antiemetics; Area Under Curve; Atropine; Erythromycin; Gastric Emptying; Horses; Metoclopramide; Parasympatholytics; Sympatholytics; Yohimbine | 1998 |
EM574, an erythromycin derivative, improves delayed gastric emptying of semi-solid meals in conscious dogs.
Topics: Animals; Atropine; Cisapride; Dogs; Erythromycin; Gastric Emptying; Gastrointestinal Agents; Gastroparesis; Male; Motilin; Muscarinic Antagonists; Receptors, Serotonin; Receptors, Serotonin, 5-HT4; Serotonin Receptor Agonists | 2000 |
Enteric locus of action of prokinetics: ABT-229, motilin, and erythromycin.
Topics: Animals; Atropine; Cell Size; Cells, Cultured; Dogs; Duodenum; Electric Stimulation; Erythromycin; Female; Gastrointestinal Agents; Gastrointestinal Motility; Hexamethonium; In Vitro Techniques; Infusions, Intra-Arterial; Intestinal Mucosa; Jejunum; Male; Methacholine Chloride; Motilin; Muscle Contraction; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Rabbits; Stomach; Tetrodotoxin | 2000 |
Erythromycin induces pyloric relaxation accompanied by a contraction of the gastric body after pylorus-preserving gastrectomy.
Topics: Animals; Atropine; Dogs; Erythromycin; Gastrectomy; Gastric Emptying; Gastrointestinal Motility; Muscle Contraction; Pylorus; Stomach | 2003 |
Direct inhibition of rat detrusor muscle contraction by erythromycin.
Topics: Adenosine Triphosphate; Animals; Anti-Bacterial Agents; Atropine; Calcium Channel Blockers; Calcium Signaling; Carbachol; Central Nervous System Depressants; Erythromycin; Ethanol; In Vitro Techniques; Muscarinic Agonists; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Nifedipine; Potassium; Rats; Rats, Wistar; Urinary Bladder | 2004 |
In vitro pharmacological characterization of mitemcinal (GM-611), the first acid-resistant non-peptide motilin receptor agonist, in smooth muscle of rabbit small intestine.
Topics: Acetylcholine; Animals; Atropine; Binding, Competitive; Calcium Chloride; Diltiazem; Dose-Response Relationship, Drug; Erythromycin; Hexamethonium; Hydrogen-Ion Concentration; In Vitro Techniques; Indoles; Intestine, Small; Male; Molecular Structure; Muscle Contraction; Muscle, Smooth; Naloxone; Rabbits; Receptors, Gastrointestinal Hormone; Receptors, Neuropeptide; Tetrodotoxin; Tropisetron; Verapamil | 2007 |
Physiological characteristics of gastric contractions and circadian gastric motility in the free-moving conscious house musk shrew (Suncus murinus).
Topics: Animals; Atropine; Behavior, Animal; Body Weight; Eating; Erythromycin; Fasting; Gastrointestinal Motility; Male; Monitoring, Physiologic; Motilin; Postprandial Period; Protein Synthesis Inhibitors; Shrews; Stomach | 2010 |